ENDOMETRIOID OVARIAN CANCER
Clinical trials for ENDOMETRIOID OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIOID OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat ovarian cancer: drug combo enters human testing
Disease control Recruiting nowThis early-phase study tests whether combining two drugs, Cirtuvivint and Olaparib, is safe for women with ovarian cancer that no longer responds to platinum chemotherapy. About 50 participants will take the medications on different schedules and visit the clinic regularly for ch…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Cancer-Killing virus shows promise in tough ovarian cancer trial
Disease control Recruiting nowThis Phase 3 study tests whether a modified virus called Olvi-Vec, given with chemotherapy and bevacizumab, can help women with ovarian cancer that no longer responds to platinum drugs. About 186 participants will receive either the virus combination or standard chemotherapy. The…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New antibody drug aims to shrink advanced tumors in early trial
Disease control Recruiting nowThis early-phase study tests an experimental drug called JNJ-89862175 in people with advanced solid tumors (lung, kidney, ovarian, or uterine cancers that have spread). The drug is designed to deliver a toxic payload directly to cancer cells. The main goals are to find a safe dos…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called JNJ-87890387 in people with advanced solid tumors that have spread or cannot be removed. The drug is designed to help the immune system attack cancer cells. The main goals are to find a safe dose and to check for side effects. About …
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Cancer-Killing virus takes on ovarian cancer in first human trial
Disease control Recruiting nowThis early-stage trial tests a new treatment called THEO-260, a virus designed to infect and destroy cancer cells. It is given directly into the abdomen to 18 people with advanced ovarian cancer that no longer responds to platinum chemotherapy. The main goals are to find a safe d…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE1 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for hard-to-treat ovarian cancer: targeted drug enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug called TORL-1-23 in women with advanced ovarian cancer that no longer responds to platinum-based chemotherapy. The drug targets a protein called claudin 6 found on cancer cells. About 230 women will receive the drug to see if it shrinks tumors and how …
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC